GlaxoSmithKline is one of the world’s leading producers of dermatological products with a range that includes widely used treatments for inflammatory dermatoses like eczema / dermatitis and psoriasis.
Over the past 30 years, GSK has developed a host of topical steroids, anti-bacterial and anti-fungal products. These ranges span the potency spectrum and are available in a variety of pharmaceutical presentations to suit all clinical needs.
Topical steroid classification
Based on topical potency:
- Mildly potent
- Moderately potent
- Very potent
There are many topical steroids on the market and users should familiarise themselves with one steroid in each category.
Clobetasone butyrate, betamethasone valerate, clobetasol propionate and mupirocin are established market leaders in a number of areas, recognised for their quality, efficacy and cost-effectiveness.
Our latest topical steroid preparation, fluticasone propionate contains one of the world’s most extensively studied steroid molecules. Fluticasone propionate is the active constituent in two other new product developments from GlaxoSmithKline – fluticasone propionate and fluticasone propionate – for the management of asthma and rhinitis.Back to top
GSK takes consumer healthcare very seriously and understands precisely what the consumer wants and needs. With nearly US$5 billion in sales and over ten US$100 million brands found worldwide, GSK is a dominant player in the market bringing over-the-counter (OTC) medication, oral healthcare and nutritional healthcare to millions of people.